- 1.Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases
- 2.Size-and Duration-Dependent Toxicity of Heavy Vehicle Tire Wear Particles in Zebrafish
- 3.Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis
- 4.miR-99a-3p Targeting EIF4EBP1 Affects B Lymphocytes Function Through Autophagy and Aggravates SLE Disease Progression
- 5.Gelatin-based dynamic response antioxidant, anti-inflammatory multifunctional hydrogel for enhanced diabetic wound repair
- 6.TRIM27 Promotes Endothelial Progenitor Cell Apoptosis in Patients with In-Stent Restenosis by Ubiquitinating TBK1
- 7.Physical Properties of the Second Type of Aciniform Spidroin (AcSp2) from Neoscona theisi Reveal a pH-Dependent Self-Assembly Repetitive Domain
- 8.Complete gene sequence and mechanical property of the fourth type of major ampullate silk protein
- 9.Characterization of two full-length tubuliform silk gene sequences from Neoscona theisi reveals intragenic concerted evolution and multiple copies in genome
“和元李记”由和元生物 (股票代码:688238) 和李记生物合资成立的,主营“李记生物”“Life-ilab”试剂品牌
返回



